Transcriptional patterns reveal tumor histologic heterogeneity and immunotherapy response in lung adenocarcinoma

Tumoral heterogeneity has proven to be a leading cause of difference in prognosis and acquired drug resistance. High intratumor heterogeneity often means poor clinical response and prognosis. Histopathological subtypes suggest tumor heterogeneity evolved during the progression of lung adenocarcinoma...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiao, Mengxue, Liu, Hui, Liu, Xuejun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393366/
https://www.ncbi.nlm.nih.gov/pubmed/36003401
http://dx.doi.org/10.3389/fimmu.2022.957751

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393366/
https://www.ncbi.nlm.nih.gov/pubmed/36003401
http://dx.doi.org/10.3389/fimmu.2022.957751

Ejemplares similares